Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SIBUR is a large Russian integrated petrochemicals company focused on processing hydrocarbons into polymers, plastics, synthetic rubbers, and other value-added chemical products. The company serves industrial end markets including packaging, automotive, construction, consumer goods, food, and healthcare-related materials applications, but it is not a life sciences or biopharmaceutical company. Its portfolio includes polyolefins, BOPP films, elastomers, PET-related products, and other petrochemical materials produced through a large manufacturing network in Russia. SIBUR also operates export and international commercial activities and has participated in major industrial joint ventures, including projects with partners such as Sinopec and Reliance. For a biotech analyst, the key point is that SIBUR is a chemicals/materials company whose relevance to healthcare is limited to supplying materials used in healthcare and pharmaceutical packaging rather than developing therapeutics, diagnostics, or medical services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIBUR.